Methods of providing therapeutic effects using cyclosporin components

CAFC
  • US 8,629,111 B2
  • Filed: 08/14/2013
  • Issued: 01/14/2014
  • Est. Priority Date: 09/15/2003
  • Status: Active Grant
First Claim
Patent Images

1. A topical ophthalmic emulsion for treating an eye of a human comprising cyclosporin A in an amount of about 0.05% by weight, polysorbate 80, acrylate/C10-30 alkyl acrylate cross-polymer, water, and castor oil in an amount of about 1.25% by weight;

  • wherein cyclosporin A is the only peptide present in the topical ophthalmic emulsion.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×